• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康相关生活质量评估的结果取决于评估时的主导节律:来自CAPTAF试验(导管消融与药物治疗心房颤动的比较)的经验。

The results of health-related quality of life assessment depend on the prevailing rhythm at the assessment: Experience from the CAPTAF trial (Catheter Ablation Compared with Pharmacological Therapy for Atrial Fibrillation).

作者信息

Jansson Victoria, Schwieler Jonas, Bergfeldt Lennart, Kennebäck Göran, Jensen Steen M, Sciaraffia Elena, Blomström-Lundqvist Carina

机构信息

Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

Department of Cardiology, Karolinska University Hospital, Solna, Stockholm, Sweden.

出版信息

J Cardiovasc Electrophysiol. 2021 Aug;32(8):2159-2164. doi: 10.1111/jce.15147. Epub 2021 Jul 12.

DOI:10.1111/jce.15147
PMID:34223671
Abstract

AIMS

To assess whether the prevailing rhythm at the time of replying to symptom and health-related quality of life (HR-QoL) questionnaires impacts the findings.

METHOD

A total of 150 patients from the randomized Catheter Ablation Compared with Pharmacological Therapy for Atrial Fibrillation-trial, comparing atrial fibrillation (AF) ablation versus drugs, were included. The effect of the prevailing rhythm on the outcome results of the HR-QoL 36-Item Short-Form Health Survey, the symptom severity questionnaire (SSQ), and the European Heart Rhythm Association (EHRA) score for classification of AF-related symptoms was assessed.

RESULTS

AF as the prevailing rhythm was independently associated with a significantly lower Vitality score; 18.4 points lower (95% confidence interval -32.7 to -4.1, p = .01) compared with sinus rhythm when adjusted for AF burden, median duration of episode, number of episodes, beta-blocker use, type of AF, and sex. The presence of AF did not affect the General Health score compared with sinus rhythm, nor did it influence symptoms assessed by the SSQ or EHRA score.

CONCLUSION

The observation that the presence of AF versus sinus rhythm when conducting HR-QoL tests had a negative impact on its outcome, leaving symptom-related questionnaires unaffected, implies that the prevailing rhythm should be taken into account when results of HR-QoL questionnaires are interpreted.

摘要

目的

评估在回复症状及健康相关生活质量(HR-QoL)问卷时的主导心律是否会影响研究结果。

方法

纳入了来自房颤导管消融与药物治疗对比试验(随机试验)的150例患者,该试验比较了房颤(AF)消融与药物治疗。评估了主导心律对HR-QoL 36项简短健康调查、症状严重程度问卷(SSQ)以及欧洲心律协会(EHRA)房颤相关症状分类评分结果的影响。

结果

房颤作为主导心律与显著更低的活力评分独立相关;在调整房颤负荷、发作的中位持续时间、发作次数、β受体阻滞剂使用情况、房颤类型和性别后,与窦性心律相比低18.4分(95%置信区间-32.7至-4.1,p = 0.01)。与窦性心律相比,房颤的存在不影响总体健康评分,也不影响通过SSQ或EHRA评分评估的症状。

结论

在进行HR-QoL测试时,房颤与窦性心律的存在对其结果有负面影响,而与症状相关的问卷不受影响,这一观察结果表明,在解释HR-QoL问卷结果时应考虑主导心律。

相似文献

1
The results of health-related quality of life assessment depend on the prevailing rhythm at the assessment: Experience from the CAPTAF trial (Catheter Ablation Compared with Pharmacological Therapy for Atrial Fibrillation).健康相关生活质量评估的结果取决于评估时的主导节律:来自CAPTAF试验(导管消融与药物治疗心房颤动的比较)的经验。
J Cardiovasc Electrophysiol. 2021 Aug;32(8):2159-2164. doi: 10.1111/jce.15147. Epub 2021 Jul 12.
2
Effect of Catheter Ablation vs Antiarrhythmic Medication on Quality of Life in Patients With Atrial Fibrillation: The CAPTAF Randomized Clinical Trial.导管消融与抗心律失常药物治疗对心房颤动患者生活质量的影响:CAPTAF 随机临床试验。
JAMA. 2019 Mar 19;321(11):1059-1068. doi: 10.1001/jama.2019.0335.
3
Atrial fibrillation burden, episode duration and frequency in relation to quality of life in patients with implantable cardiac monitor.植入式心脏监测器患者的心房颤动负荷、发作持续时间和频率与生活质量的关系
Int J Cardiol Heart Vasc. 2021 May 11;34:100791. doi: 10.1016/j.ijcha.2021.100791. eCollection 2021 Jun.
4
Patient-Reported Outcomes in Relation to Continuously Monitored Rhythm Before and During 2 Years After Atrial Fibrillation Ablation Using a Disease-Specific and a Generic Instrument.使用特定疾病和通用仪器在心房颤动消融前后 2 年监测连续节律的患者报告结局。
J Am Heart Assoc. 2018 Feb 24;7(5):e008362. doi: 10.1161/JAHA.117.008362.
5
Paroxysmal and persistent atrial fibrillation ablation outcomes with the pulmonary vein ablation catheter GOLD duty-cycled phased radiofrequency ablation catheter: quality of life and 12-month efficacy results from the GOLD Atrial Fibrillation Registry.阵发性和持续性心房颤动消融的结果与肺静脉消融导管 GOLD 定频相控射频消融导管:来自 GOLD 心房颤动登记研究的生活质量和 12 个月疗效结果。
Europace. 2020 Jun 1;22(6):888-896. doi: 10.1093/europace/euaa042.
6
Effects of Ablation Versus Drug Therapy on Quality of Life by Sex in Atrial Fibrillation: Results From the CABANA Trial.心房颤动中消融与药物治疗对生活质量的影响:CABANA 试验的性别结果。
J Am Heart Assoc. 2023 Feb 7;12(3):e027871. doi: 10.1161/JAHA.122.027871. Epub 2023 Jan 23.
7
The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification.欧洲心律协会房颤症状分类:通过简单修改进行验证与改进
Europace. 2014 Jul;16(7):965-72. doi: 10.1093/europace/eut395. Epub 2014 Feb 16.
8
Quality of life and healthcare utilisation improvements after atrial fibrillation ablation.房颤消融术后生活质量和医疗保健利用率的改善。
Heart. 2021 Aug;107(16):1296-1302. doi: 10.1136/heartjnl-2020-318676. Epub 2021 May 5.
9
Quality of life after catheter and minimally invasive surgical ablation of paroxysmal and early persistent atrial fibrillation: results from the SCALAF trial.阵发性和早期持续性心房颤动经导管和微创消融术后的生活质量:SCALAF 试验结果。
Clin Res Cardiol. 2020 Feb;109(2):215-224. doi: 10.1007/s00392-019-01504-z. Epub 2019 Jun 24.
10
Impact of redo ablation for atrial fibrillation on patient-reported outcomes and quality of life.再次消融治疗心房颤动对患者报告结局和生活质量的影响。
J Cardiovasc Electrophysiol. 2023 Jan;34(1):54-61. doi: 10.1111/jce.15710. Epub 2022 Nov 2.

引用本文的文献

1
Pre-procedural high serum visfatin and tumor necrosis factor-α might predict recurrent atrial fibrillation after catheter ablation.术前高血清内脂素和肿瘤坏死因子-α可能预测导管消融术后房颤复发。
Egypt Heart J. 2023 Jul 19;75(1):63. doi: 10.1186/s43044-023-00383-0.